Dolutegravir: A New Integrase Strand Transfer Inhibitor for the Treatment of HIV-Reference-Cited by-同舟云学术

Dolutegravir: A New Integrase Strand Transfer Inhibitor for the Treatment of HIV

Published:2013-12-18 Issue:5 Volume:34 Page:506-520
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Shah Bhavik M.¹,Schafer Jason J.¹,DeSimone Joseph A.²

Affiliation:

1. Department of Pharmacy Practice; Jefferson School of Pharmacy; Thomas Jefferson University; Philadelphia Pennsylvania

2. Division of Infectious Diseases; Jefferson Medical College; Thomas Jefferson University; Philadelphia Pennsylvania

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/phar.1386/fullpdf

Reference59 articles.

1. Department of Health and Human Services Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents, February 2013 http://www.aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf

2. Raltegravir with optimized background therapy for resistant HIV-1 infection;Steigbigel;N Engl J Med,2008

3. Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naïve human immunodeficiency virus-1-infected patients: 156-Week results from STARTMRK;Rockstroh;Clin Infect Dis,2011

4. Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate vs unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients;DeJesus;J Acquir Immune Defic Syndr,2009

5. Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States;Sax;PLoS ONE,2012

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum uric acid and high-sensitivity C-reactive protein levels among people living with HIV on dolutegravir and ritonavir-boosted atazanavir-based antiretroviral therapy: a comparative cross-sectional study;Frontiers in Medicine;2024-07-17

2. Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi;AIDS and Behavior;2024-04-13

3. Dolutegravir and the management of HIV/AIDS in the South African adult population;SA Pharmaceutical Journal;2024-04

4. Virological Non-Suppression, Non-Adherence and the Associated Factors Among People Living with HIV on Dolutegravir-Based Regimens: A Retrospective Cohort Study;HIV/AIDS - Research and Palliative Care;2024-03

5. Control over selectivity for demethylation in dolutegravir synthesis in microreactors: Kinetics and mechanisms;Chemical Engineering Science;2024-02